| scholarly article | Q13442814 |
| P50 | author | Aurora S Blucher | Q89111566 |
| Nathaniel Evans | Q90611161 | ||
| Ted Laderas | Q56991718 | ||
| P2093 | author name string | Jeffrey W Tyner | |
| Shannon K McWeeney | |||
| Molly Kulesz-Martin | |||
| Ashley Anderson | |||
| Sophia Jeng | |||
| Gabrielle Choonoo | |||
| Christina Zheng | |||
| James Jacobs | |||
| Benjamin Cordier | |||
| Mitzi Boardman | |||
| Myles Vigoda | |||
| Samuel Higgins | |||
| Steven Chamberlin | |||
| P2860 | cites work | Oral cancer in Fanconi anemia: Review of 121 cases | Q88344657 |
| Human papillomavirus and the landscape of secondary genetic alterations in oral cancers | Q90622386 | ||
| Loss of Function of Canonical Notch Signaling Drives Head and Neck Carcinogenesis | Q90823594 | ||
| Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer | Q91228785 | ||
| Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz | Q92355875 | ||
| Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Q92527773 | ||
| Evidence-Based Precision Oncology with the Cancer Targetome. | Q47893147 | ||
| Genomic analysis of head and neck cancer cases from two high incidence regions. | Q48149825 | ||
| Crosstalk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer | Q50027355 | ||
| Immunotherapy for Head and Neck Squamous Cell Carcinoma | Q53704789 | ||
| The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches. | Q54980315 | ||
| Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer. | Q55497286 | ||
| Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial | Q58082830 | ||
| Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network | Q59352781 | ||
| Iron as a Central Player and Promising Target in Cancer Progression | Q61796322 | ||
| A study of TRAIL receptors in squamous cell carcinoma of the head and neck | Q81752788 | ||
| A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome, and miRNome analysis | Q86936493 | ||
| The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma | Q87907785 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Nephrin forms a complex with adherens junction proteins and CASK in podocytes and in Madin-Darby canine kidney cells expressing nephrin | Q24670040 | ||
| Toward a Shared Vision for Cancer Genomic Data | Q26966456 | ||
| Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines | Q27686904 | ||
| Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers | Q27852227 | ||
| Comprehensive genomic characterization of head and neck squamous cell carcinomas | Q28256121 | ||
| Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
| Ten years of pathway analysis: current approaches and outstanding challenges | Q29615564 | ||
| ReactomeFIViz: a Cytoscape app for pathway and network-based data analysis | Q30859718 | ||
| Evidence for a causal association between human papillomavirus and a subset of head and neck cancers | Q33180284 | ||
| Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma | Q33566622 | ||
| Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss | Q34098286 | ||
| A lethal combination for cancer cells: synthetic lethality screenings for drug discovery | Q34132195 | ||
| Characterization of HPV and host genome interactions in primary head and neck cancers | Q34442327 | ||
| Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers | Q34760882 | ||
| Emerging landscape of oncogenic signatures across human cancers | Q35058708 | ||
| Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. | Q35893787 | ||
| Fanconi anemia: young patients at high risk for squamous cell carcinoma | Q35933293 | ||
| Quality of life research in head and neck cancer: a review of the current state of the science | Q36780354 | ||
| The Ensembl Variant Effect Predictor | Q36970975 | ||
| TRAIL induces apoptosis in oral squamous carcinoma cells--a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5. | Q37016549 | ||
| Identifying the risk factors for late-stage head and neck cancer | Q37024527 | ||
| A landscape of pharmacogenomic interactions in cancer. | Q37140236 | ||
| Applying synthetic lethality for the selective targeting of cancer. | Q38263612 | ||
| Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies. | Q38636162 | ||
| Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy | Q47303076 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 10 | |
| P921 | main subject | head and neck squamous cell carcinoma | Q18348812 |
| P304 | page(s) | e0223639 | |
| P577 | publication date | 2019-10-09 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma | |
| P478 | volume | 14 |
Search more.